Tirzepatide × Peptuvia — supplier's lab test, June 2026
COA 198691 matches Janoshik Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
The portal confirms the certificate. It can't show that a vial you buy from Peptuvia is from this batch — compare the lot on yours.
UFNU34WMCMESTest results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 40 mg · Lab measured 44.06 mg
110% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 11 mg using the measured mass, against 10 mg on the label — 10% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 198691 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Janoshik Labs's portal shows validity only |
| Weight | Listed for information — supplier-provided, not counted |
HPLC purity analysis of Tirzepatide 40mg sold by Peptuvia, ordered by its supplier and performed by Janoshik Labs on June 30, 2026. Reported purity: 99.871%. Net content: 44.06 mg against 40 mg labeled (110% of label). Tested content exceeds the labeled amount by 10%. Batch 2026061040. Sample source: supplier-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion